Shannon Thyme Klinger - 27 May 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Legal Officer
Signature
/s/ James Dillon, as Attorny-in-Fact
Issuer symbol
MRNA
Transactions as of
27 May 2025
Net transactions value
-$14,076
Form type
4
Filing time
29 May 2025, 17:13:23 UTC
Previous filing
10 Mar 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Klinger Shannon Thyme Chief Legal Officer 325 BINNEY STREET, CAMBRIDGE /s/ James Dillon, as Attorny-in-Fact 29 May 2025 0001866132

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +773 +3% 26,385 27 May 2025 Direct F1
transaction MRNA Common Stock Tax liability $9,821 -374 -1.4% $26.26 26,011 27 May 2025 Direct F2
transaction MRNA Common Stock Options Exercise +328 +1.3% 26,339 28 May 2025 Direct F1
transaction MRNA Common Stock Tax liability $4,255 -159 -0.6% $26.76 26,180 28 May 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -773 -8.3% $0.000000 8,510 27 May 2025 Common Stock 773 Direct F1, F3
transaction MRNA Restricted Stock Units Options Exercise $0 -328 -12% $0.000000 2,302 28 May 2025 Common Stock 328 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.